ATP1A1 and neuropathy: Phenotypically, clinical presentation is similar to the previous cases reported [12], although the severity of the neuropathy, in this case, was more pronounced compared to other patients of comparable age group with ATP1A1 variants (CMTNSv2 12–15 in 40–50-year-olds).